Min Tang, MD
Associate Chief Physician
Department of Oncology, Beijing Hospital
National Center of Gerontology
Institute of Geriatric Medicine, Chinese Academy of Medical Sciences
Beijing, China
Experts Committee Member
Tumor and Microecology Specialized Committee
China Anti-cancer Association

Honor:
 Committee member, Experts Committee on Cancer and Microbiology, China Anti-cancer Association
 Committee member, Experts Committee on Lung Cancer, Beijing Association of Oncology
 Committee member, Experts Committee on immunotherapy of Lung Cancer, Beijing Cancer Prevention and Treatment
 Committee member, Youth Experts Committee on Lung Cancer, Beijing Medical Award Foundation
 Committee member, Youth Experts Committee on Neuroendocrine tumors, China International Exchange and Promotion Association for Medical and Healthcare
 Youth editor,《Chinese Edition of Journal of Clinical Oncology》

Education:
M.D., Peking Union Medical College, Beijing, China

Selected publication:
 Tang Min, Li Lin, Zhang Ping, et al. The geriatric nutritional risk index predicts overall survival in geriatric patients with metastatic lung adenocarcinoma. Nutrition and cancer. 2020 Apr 2;1-9. doi: 10.1080/01635581.2020.1743865
 Tang Min, Wu Xiaonan, Guo Tan, et al. Study on the clinical and imaging features of solitary pulmonary glass nodule. Clinical medicine of China. 2017, 33(10): 895-899. doi: 10.3760/cma.j.issn.1008-6315.2017.10.008
 Tang Min, Wang Hui, Ding Li, et al. Expression of migration and invasion inhibitory protein (MIIP) in gastric adenocarcinoma and its clinicopathological significance. Chinese Journal of General Practitioners. 2017, 16(10): 791-795. doi: 10.3760/cma. j. issn.1671-7368.2017.10.012
 Tang Min, Li Lin, Wang Hui, et al. Analysis of immune regulatory factors in lymphoepithelioma-like gastric carcinoma. Chinese Clinical Doctor. 2017, 45(6): 25-29. doi: 10.3969/j.issn.2095-8552.2017.06.008
 Tang Min, Shi Xuhua, Zhang Fengchun. The characteristics of peripheral lymphocytic subsets and cytokines in primary biliary and their changes to drug treatment. Chinese Journal of Medicine. 2010, 49(2): 129-133. doi: 10.3760/cma.j.issn.0578-1426.2010.02.013
 Tang Min, Wu Xiaonan, Cheng Gang. Clinical research progress of crizotinib in ALK-positive non-small cell lung cancer patients. 2013, 33(3): 382-386.
 Tang Min, Ai Bin, Ding Li, et al. Late recurrence and metastasis of an appendiceal goblet cell carcinoid 24 years after appendectomy. Chinese Medical Journal. 2014, 127(3): 591-592
 Zhang Ping, Wu Xiaonan, Tang Min, et al. Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma. Thoracic Cancer. 2019, 10(12): 2218-2224. doi: 10.1111/1759-7714.13201. Epub 2019 Oct 10.
 Zhang Ping, Tang Min, Nie Xin, et al. Clinical characteristics associated with advanced lung adenocarcinoma patients harboring ALK rearrangements. Chinese Journal of Clinical Healthcare. 2019, 22(4): 508-511. doi: 10.3969/J.issn.1672-6790.2019.04.020
 Ding Li, Tang Min, Hu Xueqing, et al. Relationship between clinicopathologic characteristics of HER-2 overexpression and expressions of Ki-67 and p53 protein in breast cancer patients. Chinese Journal of Clinical Oncology and Rehabilitation. 2015, 22(7): 769-772. doi: 10.13455/j.cnki.cjcor.2015.07.01